Apimeds Pharmaceuticals US Settles With Inscobee and Clears Path to Complete Merger With MindWave Innovations

InMed Pharmaceuticals to Merge with Mentari Therapeutics in $290M All-Stock Deal

May 20, 2026

Biotechnology

InMed Pharmaceuticals (NASDAQ: INM) entered into a definitive all-stock merger agreement with privately held Mentari Therapeutics, creating a publicly traded migraine-focused biotech under the Mentari name. The transaction is supported by an oversubscribed $290 million private placement led by Fairmount to fund operations through 2028.

Minds + Assembly Acquires Awaken Interactive

October 31, 2024

Marketing & Advertising

Minds + Assembly, a PE-backed healthcare communications and commercialization agency, has acquired Awaken Interactive, a healthcare-focused digital marketing firm specializing in digital media, analytics, technical development and marketing automation. The deal is an add‑on to Minds + Assembly’s platform (backed by Amulet Capital Partners) to expand its analytics and digital capabilities for healthcare clients.

Otsuka Pharmaceutical Acquires Mindset Pharma

August 31, 2023

Biotechnology

Otsuka Pharmaceutical Co., Ltd., through its wholly owned U.S. subsidiary Otsuka America, Inc., agreed to acquire Mindset Pharma Inc. in an all-cash statutory plan of arrangement valued at approximately CAD 80 million. The acquisition adds Mindset’s next-generation psychedelic and non-psychedelic drug discovery assets and synthesis capabilities to Otsuka’s psychiatry and neurology pipeline.

Blue Water Ventures International Acquires Psycheceutical, Inc.

January 20, 2022

Biotechnology

Blue Water Ventures International, Inc. (BWVI) has completed a merger to acquire Psycheceutical, Inc., making the biotech a wholly-owned subsidiary. BWVI — a publicly-listed company — will pivot its business to focus on psychedelic drug development and intends to provide near-term capital as Psycheceutical advances its delivery technologies toward initial clinical trials.

NewLeaf Brands to Acquire Mindleap Health Inc.

May 20, 2020

Healthcare Services

NewLeaf Brands Inc. signed a non-binding letter of intent to acquire 100% of Mindleap Health Inc. via a share exchange, with consideration of CAD $3.5 million in NewLeaf common shares plus additional cash investments. Mindleap is a digital mental-health and telehealth platform focused on mood, emotion and habit tracking and psychedelic aftercare, and the deal is intended to accelerate Mindleap’s time-to-market and expand NewLeaf’s digital health capabilities.

Infowave Software Acquires HiddenMind Technology Assets

May 28, 2003

Software

Infowave Software agreed to acquire the assets of rival wireless enterprise provider HiddenMind Technology L.L.C. in an all-stock transaction that includes Infowave issuing roughly 15 million shares and a $3 million private investment from HiddenMind's controlling member. HiddenMind's controlling member Jerry Trooien will purchase about 30 million Infowave shares, join Infowave's board, and together with HiddenMind will hold about 40% of Infowave's common shares following the deal.